1. Home
  2. NMRA vs PDLB Comparison

NMRA vs PDLB Comparison

Compare NMRA & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • PDLB
  • Stock Information
  • Founded
  • NMRA 2019
  • PDLB 1960
  • Country
  • NMRA United States
  • PDLB United States
  • Employees
  • NMRA N/A
  • PDLB N/A
  • Industry
  • NMRA
  • PDLB
  • Sector
  • NMRA
  • PDLB
  • Exchange
  • NMRA Nasdaq
  • PDLB Nasdaq
  • Market Cap
  • NMRA 287.6M
  • PDLB 285.3M
  • IPO Year
  • NMRA 2023
  • PDLB 2017
  • Fundamental
  • Price
  • NMRA $1.13
  • PDLB $12.80
  • Analyst Decision
  • NMRA Buy
  • PDLB
  • Analyst Count
  • NMRA 8
  • PDLB 0
  • Target Price
  • NMRA $10.14
  • PDLB N/A
  • AVG Volume (30 Days)
  • NMRA 1.3M
  • PDLB 45.7K
  • Earning Date
  • NMRA 03-03-2025
  • PDLB 04-29-2025
  • Dividend Yield
  • NMRA N/A
  • PDLB N/A
  • EPS Growth
  • NMRA N/A
  • PDLB 212.14
  • EPS
  • NMRA N/A
  • PDLB 0.46
  • Revenue
  • NMRA N/A
  • PDLB $82,359,000.00
  • Revenue This Year
  • NMRA N/A
  • PDLB $10.97
  • Revenue Next Year
  • NMRA N/A
  • PDLB $8.59
  • P/E Ratio
  • NMRA N/A
  • PDLB $27.72
  • Revenue Growth
  • NMRA N/A
  • PDLB 16.30
  • 52 Week Low
  • NMRA $1.13
  • PDLB $7.89
  • 52 Week High
  • NMRA $17.19
  • PDLB $13.97
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 26.07
  • PDLB 45.82
  • Support Level
  • NMRA $1.13
  • PDLB $12.53
  • Resistance Level
  • NMRA $1.23
  • PDLB $13.07
  • Average True Range (ATR)
  • NMRA 0.12
  • PDLB 0.24
  • MACD
  • NMRA 0.05
  • PDLB 0.02
  • Stochastic Oscillator
  • NMRA 3.54
  • PDLB 37.97

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

Share on Social Networks: